Lyman-200'000 forte

Lyman-200'000 forte is a medicine authorised by Swissmedic under authorisation number 45564. The authorisation holder is Drossapharm AG. The medicinal product code is Biotechnological medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 02 April 1984 and the authorisation is valid without a time limit. ATC code C05BA53 places the medicine in the group Vasoprotectives.

  • Dispensing category D
  • Authorisation number 45564
  • ATC C05BA53
  • Biotechnological medicines
Authorisation data
Authorisation number45564
NameLyman-200'000 forte
Full nameLyman-200'000 forte, Gel
Authorisation holderDrossapharm AG
Medicinal product codeBiotechnological medicines
Dispensing categoryD · No prescription, with advice
ATC codeC05BA53
First authorisation02 April 1984
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Lyman-200'000 forte, GelD08 June 2001

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
140gC05BA5302.08.2.D
2100gC05BA5302.08.2.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Lyman-200'000 forte authorised in Switzerland?

Yes. Lyman-200'000 forte is authorised by Swissmedic under authorisation number 45564, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Lyman-200'000 forte have?

Lyman-200'000 forte is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Lyman-200'000 forte?

The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com